Associations between hemodialysis access type and clinical outcomes: A systematic review

Journal of the American Society of Nephrology

Volumn 24, Issue 3, 2013, Pages 465-473

  Ravani, Pietro ^a,b,c   Palmer, Suetonia C ^d   Oliver, Matthew J ^e   Quinn, Robert R ^a,b,c   MacRae, Jennifer M ^a   Tai, Davina J ^a,f   Pannu, Neesh I ^d   Thomas, Chandra ^a   Hemmelgarn, Brenda R ^a,b,c   Craig, Jonathan C ^h,i,j   Manns, Braden ^a,b,c   Tonelli, Marcello ^g   Strippoli, Giovanni F M ^i,j,k,l   James, Matthew T ^a,b,c  

^a UNIVERSITY OF CALGARY   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

^c LIBIN CARDIOVASCULAR INSTITUTE OF ALBERTA   (Canada)

^d UNIVERSITY OF OTAGO   (New Zealand)

^e UNIVERSITY OF TORONTO   (Canada)

^f UNIVERSITY OF SASKATCHEWAN   (Canada)

^g UNIVERSITY OF ALBERTA   (Canada)

^h CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

ⁱ University of Sydney   (Australia)

^j UNIVERSITY OF SYDNEY   (Australia)

^k MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^l Diaverum Medical Scientific Office   (Sweden)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ARTERIOVENOUS FISTULA; ARTICLE; CARDIOVASCULAR DISEASE; CENTRAL VENOUS CATHETER; CLINICAL PRACTICE; DISEASE ASSOCIATION; HEMODIALYSIS; HUMAN; INFECTION; KIDNEY FAILURE; META ANALYSIS (TOPIC); MORTALITY; PRACTICE GUIDELINE; PRIORITY JOURNAL; RISK FACTOR; SYSTEMATIC REVIEW; TREATMENT OUTCOME; VASCULAR ACCESS; VASCULAR PATENCY; VEIN GRAFT;

EID: 84874639081     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2012070643     Document Type: Article

References (32)

1. United States Renal Data System: Annual Data Report, 2011. Available at: http://www.usrds.org/adr.aspx. Accessed April 20, 2012
2. Besarab A: Resolved: Fistulas are preferred to grafts as initial vascular access for dialysis. Pro. J Am Soc Nephrol 19: 1629-1631, 2008
3. Vascular Access 2006 Work Group: Clinical practice guidelines for vascular access. AmJ Kidney Dis 48[Suppl 1]: S176-S247, 2006
4. Jindal K,ChanCT, Deziel C, Hirsch D, Soroka SD, TonelliM,Culleton BF; Canadian Society of Nephrology Committee for Clinical Practice Guidelines: Hemodialysis clinical practice guidelines for the Canadian Society of Nephrology. J Am Soc Nephrol 17[Suppl 1]: S1-S27, 2006
5. Tordoir J, Canaud B, Haage P, Konner K, Basci A, Fouque D, Kooman J, Martin-Malo A, Pedrini L, Pizzarelli F, Tattersall J, Vennegoor M, Wanner C, ter Wee P, Vanholder R: EBPG on vascular access. Nephrol Dial Transplant 22[Suppl 2]: ii88-ii117, 2007
6. The AV Fistula First Breakthrough Initiative Coalition: Arteriovenous Fistula First Website, 2012. Available at: http://www.fistulafirst.org. Accessed April 20, 2012
7. Healthy People -US Department of Health & Human Services Public Health Service: Topics and Objectives 2020 CKD-11: Improving Vascular Access for Hemodialysis Patients, 2012. Available at: http://healthypeople.gov/2020/ topicsobjectives2020/objectiveslist.aspx? topicId=6. Accessed April 20, 2012
8. NHS: Payment by Results (PbR) -Renal Dialysis, 2012. Available at: http://www.kidneycare.nhs.uk/document.php?o=574. Accessed April 20, 2012
9. Dember LM, Beck GJ, Allon M, Delmez JA, Dixon BS, Greenberg A, Himmelfarb J, VazquezMA, Gassman JJ,Greene T, RadevaMK, Braden GL, Ikizler TA, Rocco MV, Davidson IJ, Kaufman JS, Meyers CM, Kusek JW, Feldman HI; Dialysis Access Consortium Study Group: Effect of clopidogrel on early failure of arteriovenous fistulas for hemodialysis: A randomized controlled trial. JAMA 299: 2164-2171, 2008 (Pubitemid 351679707)
10. Ethier J, Mendelssohn DC, Elder SJ, Hasegawa T, Akizawa T, Akiba T, Canaud BJ, Pisoni RL: Vascular access use and outcomes: An international perspective from the Dialysis Outcomes and Practice Patterns Study. Nephrol Dial Transplant 23: 3219-3226, 2008
11. Lok CE: Fistula first initiative: Advantages and pitfalls. Clin J Am Soc Nephrol 2: 1043-1053, 2007
12. Moher D, Liberati A, Tetzlaff J, Altman DG: Preferred reporting items for systematic reviews andmeta-analyses: The PRISMA statement. Ann Intern Med 151: 264-269, 2009
13. GarcíaCortésMJ, Viedma G, Sánchez PeralesMC, Borrego FJ, Borrego J, Pérez del Barrio P, Gil Cunquero JM, Liébana A, Pérez Bañasco V: Fistulae or catheter for elderly who start hemodialysis without permanent vascular access? Nefrologia 25: 307-314, 2005
14. Hazinedaroglu SM, Tüzüner A, Ayli D, Demirer S, DumanN, YerdelMA: Femoral vein transposition versus femoral loop grafts for hemodialysis: A prospective evaluation. Transplant Proc 36: 65-67, 2004 (Pubitemid 38177190)
15. Jones SM, Ravani P, Hemmelgarn BR, Muruve D, Macrae JM: Morphometric and biological characterization of biofilm in tunneled hemodialysis catheters. Am J Kidney Dis 57: 449-455, 2011
16. Wasse H, Speckman RA, McClellan WM: Arteriovenous fistula use is associated with lower cardiovascular mortality compared with catheter use among ESRD patients. Semin Dial 21: 483-489, 2008
17. Allon M, Depner TA, Radeva M, Bailey J, Beddhu S, Butterly D, Coyne DW, Gassman JJ, Kaufman AM, Kaysen GA, Lewis JA, Schwab SJ; HEMO Study Group: Impact of dialysis dose and membrane on infection-related hospitalization and death: Results of the HEMO Study. J Am Soc Nephrol 14: 1863-1870, 2003 (Pubitemid 36750482)
18. Ravani P, Barrett B, Mandolfo S, Brunori G, Cancarini G, Imbasciati E, Malberti F: Factors associatedwithunsuccessfulutilizationandearly failure of the arterio-venousfistula forhemodialysis.JNephrol 18: 188-196,2005 (Pubitemid 40852622)
19. Palmer SC,McGregorDO,Macaskill P, Craig JC, ElderGJ, StrippoliGF: Meta-analysis: Vitamin D compounds in chronic kidney disease. Ann Intern Med 147: 840-853, 2007 (Pubitemid 351664426)
20. Palmer SC, Strippoli GF: How to read critically a prognostic cohort study. Nephrology (Carlton) 15: 676-682, 2010
21. Ioannidis JP, Haidich AB, Pappa M, Pantazis N, Kokori SI, Tektonidou MG, Contopoulos-Ioannidis DG, Lau J: Comparison of evidence of treatment effects in randomized and nonrandomized studies. JAMA 286: 821-830, 2001 (Pubitemid 33015576)
22. Hayden JA, Côté P, Bombardier C: Evaluation of the quality of prognosis studies in systematic reviews. Ann InternMed 144: 427-437, 2006 (Pubitemid 46768164)
23. Busse J, Guyatt G: An instrument for assessing risk of bias in cohort studies, 2012. Available at: http://www.evidencepartners.com/resources/. Accessed April 20, 2012
24. DerSimonian R, Laird N: Meta-analysis in clinical trials. Control Clin Trials 7: 177-188, 1986 (Pubitemid 17189972)
25. Zhang J, Yu KF: What's the relative risk? A method of correcting the odds ratio in cohort studies of common outcomes. JAMA 280: 1690-1691, 1998 (Pubitemid 28532993)
26. Miettinen O: Estimability and estimation in case-referent studies. Am J Epidemiol 103: 226-235, 1976
27. Higgins JP, Thompson SG: Quantifying heterogeneity in a meta-analysis. Stat Med 21: 1539-1558, 2002 (Pubitemid 34746062)
28. Higgins JP, Thompson SG, Deeks JJ, Altman DG: Measuring inconsistency in meta-analyses. BMJ 327: 557-560, 2003 (Pubitemid 37088507)
29. Begg CB, Mazumdar M: Operating characteristics of a rank correlation test for publication bias. Biometrics 50: 1088-1101, 1994
30. Duval S, Tweedie R: Trimand fill: A simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics 56: 455-463, 2000 (Pubitemid 30422636)
31. Polkinghorne KR, McDonald SP, Atkins RC, Kerr PG: Vascular access and all-cause mortality: A propensity score analysis. J Am Soc Nephrol 15: 477-486, 2004 (Pubitemid 38140790)
32. Foley RN, Chen SC, Collins AJ: Hemodialysis access at initiation in the United States, 2005 to 2007: Still "catheter first". Hemodial Int 13: 533-542, 2009